Itoh H - Search Results

1

Transcription factors and epigenetic modulation: its therapeutic implication in chronic kidney disease.

Hayashi K, Itoh H. Hayashi K, et al. Among authors: itoh h. Arch Immunol Ther Exp (Warsz). 2015 Jun;63(3):193-6. doi: 10.1007/s00005-014-0326-6. Epub 2014 Dec 11. Arch Immunol Ther Exp (Warsz). 2015. PMID: 25503375 Free article. Review.

2

Differential effects of transient treatment of spontaneously hypertensive rats with various antihypertensive agents on the subsequent development of diabetic nephropathy.

Ishiguro K, Sasamura H, Sakamaki Y, Hayashi K, Saruta T, Itoh H. Ishiguro K, et al. Among authors: itoh h. Nephron Exp Nephrol. 2008;109(1):e20-8. doi: 10.1159/000135386. Epub 2008 May 28. Nephron Exp Nephrol. 2008. PMID: 18506109

3

"Pulse" treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension.

Ishiguro K, Hayashi K, Sasamura H, Sakamaki Y, Itoh H. Ishiguro K, et al. Among authors: itoh h. Hypertension. 2009 Jan;53(1):83-9. doi: 10.1161/HYPERTENSIONAHA.108.122721. Epub 2008 Dec 1. Hypertension. 2009. PMID: 19047581

4

Prevention and regression of hypertension: role of renal microvascular protection.

Sasamura H, Hayashi K, Ishiguro K, Nakaya H, Saruta T, Itoh H. Sasamura H, et al. Among authors: itoh h. Hypertens Res. 2009 Aug;32(8):658-64. doi: 10.1038/hr.2009.85. Epub 2009 Jun 12. Hypertens Res. 2009. PMID: 19521419 Review.

5

Regression of glomerulosclerosis in response to transient treatment with angiotensin II blockers is attenuated by blockade of matrix metalloproteinase-2.

Hayashi K, Sasamura H, Ishiguro K, Sakamaki Y, Azegami T, Itoh H. Hayashi K, et al. Among authors: itoh h. Kidney Int. 2010 Jul;78(1):69-78. doi: 10.1038/ki.2010.81. Epub 2010 Apr 7. Kidney Int. 2010. PMID: 20375993 Free article.

6

Absence of gelatinase (MMP-9) or collagenase (MMP-13) attenuates adriamycin-induced albuminuria and glomerulosclerosis.

Sakamaki Y, Sasamura H, Hayashi K, Ishiguro K, Takaishi H, Okada Y, D'Armiento JM, Saruta T, Itoh H. Sakamaki Y, et al. Among authors: itoh h. Nephron Exp Nephrol. 2010;115(2):e22-32. doi: 10.1159/000312883. Epub 2010 Apr 21. Nephron Exp Nephrol. 2010. PMID: 20407279

7

Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathy.

Azegami T, Sasamura H, Hayashi K, Itoh H. Azegami T, et al. Among authors: itoh h. Hypertens Res. 2012 May;35(5):492-9. doi: 10.1038/hr.2011.212. Epub 2011 Dec 8. Hypertens Res. 2012. PMID: 22158111

8

Role of mineralocorticoid receptor/Rho/Rho-kinase pathway in obesity-related renal injury.

Tokuyama H, Wakino S, Hara Y, Washida N, Fujimura K, Hosoya K, Yoshioka K, Hasegawa K, Minakuchi H, Homma K, Hayashi K, Itoh H. Tokuyama H, et al. Among authors: itoh h. Int J Obes (Lond). 2012 Aug;36(8):1062-71. doi: 10.1038/ijo.2011.232. Epub 2011 Dec 20. Int J Obes (Lond). 2012. PMID: 22184057 Free PMC article.

9

Regression of atherosclerosis in apolipoprotein E-deficient mice is feasible using high-dose angiotensin receptor blocker, candesartan.

Hayashi K, Sasamura H, Azegami T, Itoh H. Hayashi K, et al. Among authors: itoh h. J Atheroscler Thromb. 2012;19(8):736-46. Epub 2012 Apr 28. J Atheroscler Thromb. 2012. PMID: 22576470 Free article.

10

KLF4-dependent epigenetic remodeling modulates podocyte phenotypes and attenuates proteinuria.

Hayashi K, Sasamura H, Nakamura M, Azegami T, Oguchi H, Sakamaki Y, Itoh H. Hayashi K, et al. Among authors: itoh h. J Clin Invest. 2014 Jun;124(6):2523-37. doi: 10.1172/JCI69557. Epub 2014 May 8. J Clin Invest. 2014. PMID: 24812666 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,980 results

Search Page

Filters